Topical treatment of pediatric patients with burns: A practical guide

American Journal of Clinical Dermatology

Volumn 3, Issue 8, 2002, Pages 529-534

  Palmieri, Tina L ^a   Greenhalgh, David G ^a  

^a SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACITRACIN; BISMUTH; CHLORHEXIDINE; LOCAL ANESTHETIC AGENT; MAFENIDE; NEOMYCIN; NEOSPORIN; NONSTEROID ANTIINFLAMMATORY AGENT; NYSTATIN; PARACETAMOL; POLYMYXIN; POLYSPORIN; SILVER NITRATE; SULFADIAZINE SILVER; VALNOCTAMIDE;

ANALGESIA; ANTIMICROBIAL ACTIVITY; BLISTER; BURN; CHILD; CHILDHOOD INJURY; CREAM; DEHYDRATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG PENETRATION; ELECTROLYTE DISTURBANCE; GRAM NEGATIVE INFECTION; HUMAN; KERNICTERUS; LEUKOPENIA; METABOLIC ACIDOSIS; METHEMOGLOBINEMIA; NEPHROTOXICITY; OINTMENT; OTOTOXICITY; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY; SKIN TRANSPLANTATION; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND HEALING IMPAIRMENT; WOUND INFECTION; WOUND IRRIGATION;

EID: 0036034270     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200203080-00003     Document Type: Review

References (15)

1. Center for Disease Control. 1990 Mortality Data. Atlanta (GA): Center for Disease Control. 1990
2. Yurt RW, McManus AT, Mason AD, et al. Increased susceptibility to infection related to extent of burn injury. Arch Surg 1984; 119: 183-8
3. Hunt JL, Sato RM. Early excision of full thickness hand and digit burns: Factors affecting morbidity. J Trauma 1982; 22: 414-9
4. Wolf SE, Rose JK, Desai MH, et al. Mortality determinants in massive pediatric burns. Ann Surg 1997; 225: 554-69
5. Herndon DN, Barrow RE, Rutan RL, et al. A comparison of conservative versus early excision therapies in severely burned patients. Ann Surg 1989; 209: 547-52
6. Sheridan RT, editor. Advanced Burn Life Support Provider Manual. Chicago (IL): American Burn Association, 2001: 13-23
7. Lund C, Browder NC. The estimation of areas of burns. Surg Gynecol Obstet 1944; 79: 352-8
8. Jacobs MR, Zanowiak P. Topical anti-infective products. In: Feldman EG, editor. Handbook of Nonprescriptive Drugs. 9th Ed. Washington, DC: American Pharmaceutical Association. 1990: 779-81
9. Taddonio TE, Thomson PD, Smith Jr DJ, et al. A survey of wound monitoring and topical antimicrobial therapy practices in the treatment of burn injury. J Burn Care Rehabil 1990; 11: 423-7
10. Sheth KV, Abdulatiff M, Al-Sedairy S. Effects of bacitracin on the human neutrophil oxidative respiratory burst and chemotaxis. Int J Immunopathol Pharmacol 1993; 6 (1): 43-9
11. Monafo WW, West MA. Current treatment recommendations for topical burn therapy. Drugs 1990; 40: 364-73
12. Kaiser W, Von der Lieth H, Potel J, et al. Local application of silver sulfadiazine, cefsulodin and povidone iodine on burns in animals: An experimental study. Infection 1984; 12 (1): 31-5
13. Lineaweaver W, McMorris S, Soucy D, et al. Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg 1985; 75: 394-6
14. Ward RS, Saffle JR. Topical agents in burn and wound care. Phys Ther 1995; 75: 526-38
15. Lee JJ, Marvin JA, Heimbach DM, et al. Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns. J Burn Care Rehabil 1988; 9 (6): 602-5